Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$42.05 - $47.77 $75,059 - $85,269
-1,785 Reduced 11.23%
14,109 $614,000
Q4 2021

Feb 10, 2022

SELL
$38.88 - $45.31 $9,408 - $10,965
-242 Reduced 1.5%
15,894 $701,000
Q3 2021

Oct 26, 2021

SELL
$38.79 - $43.16 $21,528 - $23,953
-555 Reduced 3.33%
16,136 $616,000
Q2 2021

Jul 29, 2021

BUY
$36.52 - $41.46 $10,043 - $11,401
275 Added 1.68%
16,691 $665,000
Q1 2021

Apr 23, 2021

SELL
$34.27 - $40.01 $32,213 - $37,609
-940 Reduced 5.42%
16,416 $585,000
Q4 2020

Feb 11, 2021

SELL
$34.07 - $39.94 $15,365 - $18,012
-451 Reduced 2.53%
17,356 $639,000
Q3 2020

Nov 12, 2020

SELL
$38.11 - $42.99 $58,041 - $65,473
-1,523 Reduced 7.88%
17,807 $670,000
Q2 2020

Aug 13, 2020

SELL
$37.87 - $43.58 $984 - $1,133
-26 Reduced 0.13%
19,330 $788,000
Q1 2020

May 08, 2020

BUY
$32.47 - $48.83 $2,922 - $4,394
90 Added 0.47%
19,356 $733,000
Q4 2019

Feb 11, 2020

SELL
$42.0 - $48.25 $10,500 - $12,062
-250 Reduced 1.28%
19,266 $905,000
Q3 2019

Oct 24, 2019

SELL
$40.46 - $43.52 $7,404 - $7,964
-183 Reduced 0.93%
19,516 $833,000
Q2 2019

Aug 15, 2019

SELL
$39.4 - $42.7 $21,709 - $23,527
-551 Reduced 2.72%
19,699 $788,000
Q1 2019

May 15, 2019

SELL
$38.57 - $42.69 $5,978 - $6,616
-155 Reduced 0.76%
20,250 $846,000
Q4 2018

Feb 15, 2019

BUY
$37.8 - $42.69 $27,291 - $30,822
722 Added 3.67%
20,405 $779,000
Q3 2018

Nov 15, 2018

SELL
$39.75 - $42.69 $9,261 - $9,946
-233 Reduced 1.17%
19,683 $791,000
Q2 2018

Aug 14, 2018

BUY
$39.61 - $42.76 $12,992 - $14,025
328 Added 1.67%
19,916 $802,000
Q1 2018

May 15, 2018

BUY
$36.18 - $40.15 $52,461 - $58,217
1,450 Added 7.99%
19,588 $766,000
Q4 2017

Aug 28, 2019

SELL
$35.34 - $41.9 $7,138 - $8,463
-202 Reduced 1.1%
18,138 $643,000
Q4 2017

Feb 15, 2018

SELL
$35.34 - $41.9 $84,851 - $100,601
-2,401 Reduced 11.58%
18,340 $650,000
Q3 2017

Nov 14, 2017

BUY
$39.44 - $41.55 $818,025 - $861,788
20,741
20,741 $842,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $74B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.